Pear Therapeutics, Inc. Sustainability Profile
Pear Therapeutics, Inc., a pioneering leader in the digital therapeutics industry, is headquartered in the United States. Founded in 2013, the company has made significant strides in developing prescription digital therapeutics designed to treat various mental health and substance use disorders. With a focus on evidence-based solutions, Pear Therapeutics offers unique products such as reSET and reSET-O, which integrate seamlessly with traditional therapies to enhance patient outcomes. These innovative offerings set the company apart in a rapidly evolving market, positioning it as a key player in the intersection of technology and healthcare. Recognised for its commitment to advancing therapeutic options, Pear Therapeutics continues to shape the future of treatment through its cutting-edge digital solutions, addressing critical needs in patient care.
DitchCarbon Score
How does Pear Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pear Therapeutics, Inc.'s score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pear Therapeutics, Inc.'s reported carbon emissions
Pear Therapeutics, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Pear Therapeutics may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives at this time. As the company operates within the healthcare technology sector, it may face increasing pressure to adopt sustainable practices and transparency in emissions reporting in line with broader industry trends.
How Carbon Intensive is Pear Therapeutics, Inc.'s Industry?
How Carbon Intensive is Pear Therapeutics, Inc.'s Location?
Pear Therapeutics, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Pear Therapeutics, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.